cabergoline has been researched along with Depressive Disorder, Major in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Ciftci, S; Ersungur, EB; Gul, N; Kadioglu, P; Ozkaya, HM; Poyraz, BC; Sahin, S; Sarac, B; Sulu, C; Tanrikulu, S; Tanriover, E; Yener Ozturk, F | 1 |
Baumgarten, E; Connemann, B; Feneberg, E; Gahr, M; Merger, S; Özpeynirci, Y; Schönfeldt-Lecuona, C | 1 |
Higuchi, H; Sugawara, Y; Yoshida, K | 1 |
Davie, M | 1 |
4 other study(ies) available for cabergoline and Depressive Disorder, Major
Article | Year |
---|---|
Risk of impulse control disorders in patients with Cushing's disease: do not blame cabergoline but do not give up caution.
Topics: Cabergoline; Cross-Sectional Studies; Depressive Disorder, Major; Disruptive, Impulse Control, and Conduct Disorders; Humans; Pituitary ACTH Hypersecretion; Prospective Studies | 2023 |
Prolactin serum concentrations after electroconvulsive therapy in a depressed patient with cabergoline-treated prolactinoma: implications for treatment.
Topics: Antidepressive Agents; Antineoplastic Agents; Cabergoline; Depressive Disorder, Major; Electroconvulsive Therapy; Ergolines; Female; Humans; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma | 2015 |
Dramatic remission of treatment-resistant depression after the cessation of tricyclic antidepressants.
Topics: Adult; Antidepressive Agents, Tricyclic; Cabergoline; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Female; Fluvoxamine; Humans; Imipramine; Substance Withdrawal Syndrome; Treatment Outcome | 2006 |
Pathological gambling associated with cabergoline therapy in a patient with a pituitary prolactinoma.
Topics: Antidepressive Agents; Antineoplastic Agents; Cabergoline; Citalopram; Delusions; Depressive Disorder, Major; Ergolines; Female; Gambling; Humans; Middle Aged; Pituitary Neoplasms; Prolactinoma | 2007 |